Non-invasive Secondary Respiratory Support in Late Preterm and Term Infants
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of the present work is to compare between various modes of non-invasive respiratory support (including NCPAP, NIPPV, and NHFOV) as secondary respiratory support modes in late preterm and term neonates as regards the need for reintubation. Additionally, the study aims at comparing between the three modes concerning the associated morbidity and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2022
CompletedFirst Submitted
Initial submission to the registry
May 23, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedMay 31, 2025
January 1, 2025
6 months
May 23, 2025
May 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Failure rate
need for reintubation and invasive mechanical ventilation
72 hours after weaning
Secondary Outcomes (1)
duration of non-invasive ventilation
first 72 hours after weaning from mechanical ventillation
Study Arms (3)
Nasal Continuous positive airway pressure (NCPAP)
ACTIVE COMPARATORapply continuous positive airway pressure using nasopharyngeal interface. positive end expiratory pressure (PEEP ) used 5-7 cm H2O. Neonates will be supported with NCPAP following extubation.
Nasal intermittent pressure ventilation (NIPPV)
ACTIVE COMPARATORNeonates will be supported with NIPPV following extubation.
Nasal high frequency ventilation (NHFOV)
ACTIVE COMPARATORNeonates will be supported with NHFOV following extubation. stating mean airway pressure 8 and can reach upto 15 cm H2O Delta pressure used is 20 Frequency 10 HZ
Interventions
Apply nasal continuous positive airway pressure in intubated patients with respiratory distress at time of weaning
Apply nasal intermittent positive pressure ventilation in intubated patients with respiratory distress at time of weaning
Apply nasal high frequency ventilation in intubated patients with respiratory distress at time of weaning
Eligibility Criteria
You may qualify if:
- The gestational age (GA) is between 34 and 41 weeks.
- Extubation from invasive mechanical ventilation initiated due to RD, irrespective to the cause of RD.
- Respiratory distress is assessed based on clinical manifestations (tachypnea, nasal flaring, intercostal retractions, diminished air entry, and or grunting)
You may not qualify if:
- Major congenital anomalies.
- Major cardiac diseases.
- Presence of cardiovascular instability (sepsis, severe dehydration, severe anemia).
- Neurologically insulted neonates who are unable to take adequate spontaneous breathing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marwa Mohamed Farag
Alexandria, 0325, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor of Pediatrics
Study Record Dates
First Submitted
May 23, 2025
First Posted
May 31, 2025
Study Start
July 1, 2021
Primary Completion
December 30, 2021
Study Completion
January 30, 2022
Last Updated
May 31, 2025
Record last verified: 2025-01